R&D Expenses
$2.43B
TTM · Period ending: · USD

ONC R&D Expenses
What is r&d expenses?
Research and development spending.
ONC r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | R&D Expenses (USD) | Change |
|---|---|---|
| 2,145,868,000 | +9.86% | |
| 1,953,295,000 | +9.82% | |
| 1,778,594,000 | +8.42% | |
| 1,640,508,000 | +12.42% | |
| 1,459,239,000 | +12.69% | |
| 1,294,877,000 | +39.63% | |
| 927,338,000 | +36.57% | |
| 679,005,000 | +152.40% | |
| 269,018,000 | +174.42% | |
| 98,033,000 | +68.30% | |
| 58,250,000 | +166.44% | |
| 21,862,000 | +62.39% | |
| 13,463,000 | — |
Frequently asked questions: ONC r&d expenses
What is BeOne Medicines AG (ONC)'s current r&d expenses?
BeOne Medicines AG (ONC)'s latest reported r&d expenses (TTM) is $2.43B as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for ONC?
Stock Alarm Pro provides 13 dated annual fiscal periods observations for BeOne Medicines AG (ONC)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare ONC's r&d expenses to peers or set an alert?
You can open ONC's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ONC delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance